커넥티드 의료기기 시장 : 시장 예측 - 기기 유형별, 컴포넌트별, 도입 형태별, 치료 영역별, 용도별, 최종 사용자별 및 지역별 분석(-2034년)

According to Stratistics MRC, the Global Connected Medical Devices Market is accounted for $93.5 billion in 2026 and is expected to reach $363.6 billion by 2034 growing at a CAGR of 18.5% during the forecast period. The Connected Medical Devices Market encompasses digitally enabled healthcare devices that use connectivity features to collect, transmit, and analyze medical data for better healthcare delivery. It includes wearable devices, smart monitoring systems, connected diagnostic tools, implantable technologies, and remote care solutions that facilitate real-time health information exchange. These devices leverage technologies such as IoT connectivity, wireless networks, cloud computing, and advanced data analytics to assist healthcare professionals in monitoring patients and making informed decisions. Serving hospitals, clinics, and home healthcare environments, connected medical devices contribute to modern healthcare systems by supporting continuous monitoring, efficient management, and improved patient care experiences.

Market Dynamics:

Driver:

Increasing Demand for Remote Patient Monitoring

The increasing adoption of remote healthcare monitoring solutions significantly supports the Connected Medical Devices Market by enabling healthcare professionals to observe patients continuously beyond hospitals and clinics. Wearable devices, connected sensors, and digital monitoring platforms provide timely health data that helps identify potential complications and improve treatment management. These technologies reduce dependency on frequent hospital appointments while enhancing patient convenience and care accessibility. The growing requirement for managing chronic diseases and delivering efficient home-based healthcare services is accelerating the integration of connected medical devices into modern healthcare systems, allowing more personalized and proactive approaches to patient management.

Restraint:

High Cost of Connected Medical Devices

Expensive implementation and ownership costs represent a key challenge for the Connected Medical Devices Market, particularly among budget-constrained healthcare providers and consumers. Connected medical technologies require investments in advanced hardware, digital platforms, network systems, and ongoing maintenance, which can increase financial pressure. Many healthcare facilities may hesitate to adopt these solutions due to infrastructure upgrade requirements and limited funding availability. Similarly, patients may experience affordability issues when purchasing advanced monitoring devices without adequate reimbursement options. These financial barriers can restrict widespread adoption and prevent equal access to connected healthcare technologies across different regions and healthcare environments.

Opportunity:

Increasing Healthcare Digitization in Emerging Markets

Healthcare digital transformation across emerging economies offers significant opportunities for connected medical device companies by increasing demand for technology-enabled healthcare services. Developing regions are adopting digital platforms, telehealth systems, and connected monitoring solutions to overcome limitations in healthcare availability. Connected devices can help improve remote patient management, expand access to medical expertise, and support efficient healthcare delivery in underserved areas. Government investments and healthcare improvement initiatives are encouraging greater adoption of digital technologies. This creates opportunities for manufacturers to develop cost-effective and scalable connected medical solutions designed specifically for the requirements of emerging healthcare markets.

Threat:

Regulatory Changes and Compliance Uncertainty

Evolving regulations and uncertain compliance environments create difficulties for connected medical device companies by requiring frequent adjustments to product designs and operational processes. Regulatory authorities continue to introduce new requirements related to cybersecurity, device performance, patient privacy, and digital healthcare standards. Companies operating across multiple regions must manage different approval processes, increasing complexity and expenses. These regulatory challenges may extend development timelines and create barriers for market entry. Smaller technology providers may face greater difficulties in maintaining compliance. Continuous regulatory changes can therefore slow innovation, increase costs, and create uncertainty for stakeholders involved in connected healthcare solutions.

Covid-19 Impact:

The COVID-19 outbreak had a notable impact on the Connected Medical Devices Market by strengthening the need for virtual care, remote monitoring, and digitally connected healthcare solutions. Healthcare providers adopted connected technologies to manage patients outside hospitals, minimize infection risks, and address increasing healthcare demands during the pandemic. Remote monitoring devices, wearable technologies, and connected diagnostic solutions supported continuous patient observation and improved healthcare accessibility. The pandemic increased awareness of digital healthcare infrastructure and encouraged greater integration of connected medical technologies. At the same time, disruptions in global supply chains and manufacturing operations created short-term challenges for device availability and production activities.

The Vital Sign Monitoring Devices segment is expected to be the largest during the forecast period

The Vital Sign Monitoring Devices segment is expected to account for the largest market share during the forecast period, supported by the growing need for continuous and efficient health monitoring solutions. Connected vital sign devices allow healthcare professionals and patients to track important physiological indicators in real time, improving patient management and supporting timely medical intervention. The integration of wearable technologies, wireless connectivity, and remote monitoring platforms is expanding the use of these devices across various healthcare settings. Their importance in hospitals, home-based care, and long-term disease monitoring contributes to their leading position within the connected medical devices landscape.

The Remote Patient Monitoring segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Remote Patient Monitoring segment is predicted to witness the highest growth rate, due to the increasing demand for continuous healthcare monitoring outside traditional clinical environments. This segment enables healthcare providers to track patient health conditions remotely through connected devices, wearable monitors, and digital platforms. The growing need for managing chronic conditions, reducing hospital visits, and improving healthcare accessibility is accelerating the adoption of remote monitoring solutions. Integration of wireless connectivity, cloud-based healthcare systems, and real-time data analysis further supports the expansion of remote patient monitoring applications across homecare, hospitals, and long-term care settings.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by its well-established healthcare infrastructure, advanced digital healthcare ecosystem, and strong acceptance of connected medical technologies. The region has experienced increasing implementation of remote monitoring systems, smart medical devices, and connected healthcare platforms across various care settings. Supportive healthcare initiatives, technology investments, and the presence of major industry participants contribute to the region's leading position. Furthermore, rising emphasis on personalized care, chronic disease management, and efficient healthcare delivery is driving the utilization of connected medical devices throughout hospitals, healthcare facilities, and home-based care environments.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, supported by the rapid transformation of healthcare systems and increasing implementation of digital health solutions. The region is experiencing greater adoption of remote monitoring devices, connected healthcare platforms, and smart medical technologies to enhance patient care accessibility. Growing healthcare requirements, increasing prevalence of chronic conditions, and advancements in communication infrastructure are driving demand for connected medical solutions. Government efforts toward healthcare modernization and investments in technology-based care models are creating favorable opportunities for market expansion, enabling Asia Pacific to become a key region for connected medical device adoption.

Key players in the market

Some of the key players in Connected Medical Devices Market include Google LLC, Microsoft Corporation, Oracle Corporation, Amazon Web Services, Inc., IBM Corporation, Salesforce, Inc., WSO2 LLC, MuleSoft LLC, Boomi, LP, Axway Software SA, Kong Inc., Red Hat, Inc., InterSystems Corporation, NextGen Healthcare, Inc., Innovaccer Inc., Smile Digital Health Inc., Redox, Inc. and Health Gorilla, Inc.

Key Developments:

In March 2026, Google announced a partnership with DocMorris to create a more personalized digital health experience in Europe by combining DocMorris' healthcare expertise with Google's AI capabilities and Google Cloud infrastructure.

In February 2026, Oracle Health introduced the Oracle Health Device Validation Program to strengthen collaboration with medical device vendors by providing a standardized framework for validating device connectivity, functionality, and workflow integration.

In January 2026, Innovaccer announced a strategic partnership with Coforge to accelerate AI-driven healthcare transformation.

Components Covered:

• Platform
• Services

Deployment Modes Covered:

• Cloud-Based
• On-Premises
• Hybrid

Organization Sizes Covered:

• Large Enterprises
• Small & Medium-Sized Enterprises (SMEs)

API Types Covered:

• Open APIs
• Partner APIs
• Internal APIs
• Composite APIs

API Architectures Covered:

• REST APIs
• SOAP APIs
• GraphQL APIs
• gRPC APIs
• FHIR-Based APIs

Functionalities Covered:

• API Gateway
• API Security & Access Control
• API Analytics & Monitoring
• API Lifecycle Management
• API Developer Portal
• API Traffic Management
• API Integration & Orchestration
• API Monetization

Integration Types Covered:

• Electronic Health Record (EHR) Integration
• Electronic Medical Record (EMR) Integration
• Health Information Exchange (HIE) Integration
• Laboratory Information System (LIS) Integration
• Radiology Information System (RIS) Integration
• Pharmacy Information System (PIS) Integration
• Revenue Cycle Management (RCM) Integration
• Patient Engagement Platform Integration
• Claims & Billing System Integration
• Remote Patient Monitoring (RPM) Integration

Applications Covered:

• Clinical Data Exchange
• Patient Engagement & Patient Portals
• Telehealth & Virtual Care
• Care Coordination
• Population Health Management
• Claims Processing & Reimbursement
• Clinical Decision Support
• Digital Therapeutics Integration
• Healthcare Analytics
• Clinical Trial Data Exchange

End Users Covered:

• Healthcare Providers
• Healthcare Payers
• Pharmaceutical & Biotechnology Companies
• Medical Device Companies
• Clinical Research Organizations (CROs)
• Health Information Exchanges (HIEs)
• Government & Public Health Organizations
• Digital Health & HealthTech Companies

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Connected Medical Devices Market, By Device Type

• 5.1 Vital Sign Monitoring Devices
• 5.2 Cardiac Monitoring Devices
• 5.3 Respiratory Monitoring Devices
• 5.4 Diabetes Management Devices
• 5.5 Neurology Monitoring Devices
• 5.6 Sleep Monitoring Devices
• 5.7 Fetal & Neonatal Monitoring Devices
• 5.8 Connected Infusion Devices
• 5.9 Connected Imaging Devices
• 5.10 Smart Medication Delivery Devices
• 5.11 Connected Implantable Devices
• 5.12 Connected Therapeutic Devices
• 5.13 Connected Rehabilitation Devices
• 5.14 Other Connected Medical Devices

6 Global Connected Medical Devices Market, By Connectivity Technology

• 6.1 Bluetooth
• 6.2 Wi-Fi
• 6.3 Cellular Connectivity
• 6.4 Near Field Communication
• 6.5 Zigbee
• 6.6 RFID
• 6.7 LPWAN
• 6.8 Ethernet

7 Global Connected Medical Devices Market, By Component

• 7.1 Hardware
• 7.2 Software
• 7.3 Services

8 Global Connected Medical Devices Market, By Deployment Mode

• 8.1 Cloud-Based
• 8.2 On-Premises
• 8.3 Hybrid

9 Global Connected Medical Devices Market, By Therapeutic Area

• 9.1 Cardiology
• 9.2 Diabetes
• 9.3 Neurology
• 9.4 Respiratory Disorders
• 9.5 Oncology
• 9.6 Orthopedics
• 9.7 Obstetrics & Gynecology
• 9.8 Nephrology
• 9.9 Infectious Diseases

10 Global Connected Medical Devices Market, By Application

• 10.1 Remote Patient Monitoring
• 10.2 Chronic Disease Management
• 10.3 Medication Management
• 10.4 Hospital Workflow Management
• 10.5 Emergency & Critical Care Monitoring
• 10.6 Post-Acute Care Monitoring
• 10.7 Clinical Research
• 10.8 Preventive Healthcare & Wellness Monitoring

11 Global Connected Medical Devices Market, By End User

• 11.1 Hospitals
• 11.2 Specialty Clinics
• 11.3 Ambulatory Surgical Centers
• 11.4 Diagnostic Centers
• 11.5 Home Healthcare Providers
• 11.6 Long-Term Care Facilities
• 11.7 Rehabilitation Centers
• 11.8 Research & Academic Institutes

12 Global Connected Medical Devices Market, By Geography

• 12.1 North America
  • 12.1.1 United States
  • 12.1.2 Canada
  • 12.1.3 Mexico
• 12.2 Europe
  • 12.2.1 United Kingdom
  • 12.2.2 Germany
  • 12.2.3 France
  • 12.2.4 Italy
  • 12.2.5 Spain
  • 12.2.6 Netherlands
  • 12.2.7 Belgium
  • 12.2.8 Sweden
  • 12.2.9 Switzerland
  • 12.2.10 Poland
  • 12.2.11 Rest of Europe
• 12.3 Asia Pacific
  • 12.3.1 China
  • 12.3.2 Japan
  • 12.3.3 India
  • 12.3.4 South Korea
  • 12.3.5 Australia
  • 12.3.6 Indonesia
  • 12.3.7 Thailand
  • 12.3.8 Malaysia
  • 12.3.9 Singapore
  • 12.3.10 Vietnam
  • 12.3.11 Rest of Asia Pacific
• 12.4 South America
  • 12.4.1 Brazil
  • 12.4.2 Argentina
  • 12.4.3 Colombia
  • 12.4.4 Chile
  • 12.4.5 Peru
  • 12.4.6 Rest of South America
• 12.5 Rest of the World (RoW)
  • 12.5.1 Middle East
    • 12.5.1.1 Saudi Arabia
    • 12.5.1.2 United Arab Emirates
    • 12.5.1.3 Qatar
    • 12.5.1.4 Israel
    • 12.5.1.5 Rest of Middle East
  • 12.5.2 Africa
    • 12.5.2.1 South Africa
    • 12.5.2.2 Egypt
    • 12.5.2.3 Morocco
    • 12.5.2.4 Rest of Africa

13 Strategic Market Intelligence

• 13.1 Industry Value Network and Supply Chain Assessment
• 13.2 White-Space and Opportunity Mapping
• 13.3 Product Evolution and Market Life Cycle Analysis
• 13.4 Channel, Distributor, and Go-to-Market Assessment

14 Industry Developments and Strategic Initiatives

• 14.1 Mergers and Acquisitions
• 14.2 Partnerships, Alliances, and Joint Ventures
• 14.3 New Product Launches and Certifications
• 14.4 Capacity Expansion and Investments
• 14.5 Other Strategic Initiatives

15 Company Profiles

• 15.1 Medtronic plc
• 15.2 Koninklijke Philips N.V.
• 15.3 GE HealthCare Technologies Inc.
• 15.4 Siemens Healthineers AG
• 15.5 Abbott Laboratories
• 15.6 Boston Scientific Corporation
• 15.7 Stryker Corporation
• 15.8 Omron Healthcare, Inc.
• 15.9 Dexcom, Inc.
• 15.10 Insulet Corporation
• 15.11 ResMed Inc.
• 15.12 Withings
• 15.13 iRhythm Technologies, Inc.
• 15.14 AliveCor, Inc.
• 15.15 Masimo Corporation
• 15.16 ZOLL Medical Corporation
• 15.17 Eko Health, Inc.
• 15.18 Biofourmis